查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495536

非諾貝林市場：按產品類型、應用和最終用途分類 - 全球預測 2024-2030

Fenoverine Market by Product Type (Capsules, Tablets), Application (Abdominal Spasms, Stomach Spasms), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年苯諾維林市場規模為2.2654億美元，2024年達2.3771億美元，預計2030年將達3.1932億美元，複合年成長率為5.02%。

非諾貝林是一種主要用於治療各種消化系統疾病的藥物。透過放鬆胃腸道的平滑肌，苯諾維林可以緩解腹痛、腹脹和不適等症狀，這些症狀通常與大腸激躁症和類似的消化系統疾病有關。非諾貝林被歸類為解痙藥，可減少消化器官系統痙攣和不自主的肌肉收縮。這一動作可以改善患有這些問題的患者的舒適度和消化功能。全球胃腸道疾病（包括大腸激躁症和痙攣性疼痛）盛行率不斷上升，以及對開發更安全、更有效製劑的穩定投資正在推動市場成長。然而，替代治療技術和藥物的可用性以及苯諾維林的嚴重副作用可能會阻礙市場的採用。然而，改進的藥物輸送系統（如緩釋性膠囊和水溶性錠劑）的開發，以及製藥公司和學術機構之間合作的加強，預計將推動苯諾威林研發過程的創新和效率。市場創造進一步的成長機會。

主要市場統計
基準年[2023] 22654萬美元
預測年份 [2024] 23771萬美元
預測年份 [2030] 31932萬美元
複合年成長率（%） 5.02%

區域洞察

美洲苯諾威林市場的成長主要是由於人們對大腸激躁症（IBS）和苯諾威林用於治療的類似胃腸道疾病的認知不斷提高。在這些地區，獲得醫療保健服務的機會很高，患者通常對處方治療表現出很高的依從性。最近的投資旨在改進配方並儘量減少可能的副作用。歐洲市場格局是動態的，受醫療保健政策和監管差異的影響，各國之間的市場動態有顯著差異。近年來，歐洲在胃腸道疾病研究上投入大量資金，部分原因是歐盟衛生計畫的資助。這可能會增加理解和認知，並增加對包括非諾貝林在內的治療的需求。歐盟的專利活動主要圍繞著改善現有藥物的藥理學特徵和減少藥物引起的副作用的發生率。由於最近努力改善醫療設施和跨國製藥公司增加投資，中東和非洲的苯諾維林市場正在擴大。由於生活方式引起的胃腸道疾病的增加，特別是在都市區，亞太地區的苯維林市場呈現快速成長。一個主要促進因素是整個亞太地區不斷擴大的醫療基礎設施以及政府為改善人口整體健康所做的努力。此外，先進的醫學研究和製藥創新已導致針對該主題申請了多項新專利_KEYWORD，重點關注增強的遞送機制和聯合治療。

FPNV定位矩陣

FPNV 定位矩陣對於評估 Fenoberine 市場供應商定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對非諾貝林市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對當前非諾貝林市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對有效胃腸道治療的認知與需求不斷增強
      • 擴大醫療基礎設施和政府努力
    • 抑制因素
      • 與苯諾維林相關的限制和副作用
    • 機會
      • 苯維林給藥系統的進展
      • 聯合研究和開發舉措
    • 任務
      • 假藥的存在、替代治療技術和藥物的可用性
  • 市場區隔分析
    • 產品類型：極少的味道和氣味使苯諾維林膠囊更受歡迎
    • 最終用途：家庭醫療保健環境中苯諾維林使用的演變
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章非諾貝林市場：依產品類型

  • 膠囊
  • 藥片

第 7 章非諾貝林市場：依應用分類

  • 腹部絞痛
  • 胃痙攣

第 8 章 非諾貝林市場：依最終用途分類

  • 家庭健康環境
  • 醫院/診所

第9章 美洲非諾貝林市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太非諾貝林市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 非諾貝林歐洲、中東和非洲市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 布吉納法索開設新製藥廠以促進健康獨立和經濟成長
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-CB04E05652A0

[181 Pages Report] The Fenoverine Market size was estimated at USD 226.54 million in 2023 and expected to reach USD 237.71 million in 2024, at a CAGR 5.02% to reach USD 319.32 million by 2030.

Fenoverine is a pharmaceutical drug primarily used to treat various digestive disorders. It works by helping to relax the smooth muscles of the gastrointestinal tract, which can alleviate symptoms, including abdominal pain, bloating, and discomfort often associated with conditions including irritable bowel syndrome and similar gastrointestinal ailments. Fenoverine is classified as a spasmolytic agent, which helps reduce spasms or involuntary muscle contractions in the digestive system. This action helps improve the comfort and digestive function of patients experiencing these issues. The rising global incidence of gastrointestinal disorders, including irritable bowel syndrome and spasmodic pain, and the steady flow of investment into developing safer and more effective formulations drive the market growth. However, the availability of alternate therapeutic technologies and medicines coupled with significant side effects for fenoverine can deter the adoption of the market. Nevertheless, developing improved drug delivery systems, such as extended-release capsules or soluble tablets, and increasing collaborations between pharmaceutical companies and academic institutions are anticipated to spur innovation and efficiency in the R&D processes for fenoverine, further creating market growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 226.54 million
Estimated Year [2024] USD 237.71 million
Forecast Year [2030] USD 319.32 million
CAGR (%) 5.02%

Regional Insights

The market for fenoverine in the Americas shows growth, primarily due to the growing awareness of irritable bowel syndrome (IBS) and similar gastrointestinal conditions for which fenoverine is prescribed. In these regions, there is high access to healthcare services, and patients generally exhibit high compliance with prescribed treatments. Recent investments have been directed toward improving the formulation and minimizing possible side effects of the drug. The European market for fenoverine presents a varied landscape, with considerable differences in market dynamics from one country to another, influenced by differing healthcare policies and regulations. Recently, there has been significant investment in research into gastrointestinal diseases in Europe, partly funded by the EU's health programs. This has facilitated better understanding and awareness, potentially increasing the need for treatments, including fenoverine. Patent activity in the EU primarily revolves around improving the pharmacological profiles of existing drugs and reducing the incidence of drug-induced side effects. In the Middle East and Africa, the market for fenoverine is growing with recent initiatives aimed at boosting healthcare facilities, coupled with increasing investments from multinational pharmaceutical companies. The Asia-Pacific region is showcasing rapid growth in the fenoverine market, propelled by rising incidences of lifestyle-induced gastrointestinal disorders, particularly in urban areas. Expanding healthcare infrastructure and governmental initiatives to improve the population's general health across APAC are significant drivers. Furthermore, advanced medical research and pharmaceutical innovations have seen several new patents filed for fenoverine, focusing on enhanced delivery mechanisms and combination therapies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Fenoverine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing awareness and the need for effective gastrointestinal treatments
      • Expanding healthcare infrastructure and governmental initiatives
    • Market Restraints
      • Limitations and side effects associated with fenoverine
    • Market Opportunities
      • Advancements in drug delivery systems for fenoverine
      • Collaborative research and development initiatives
    • Market Challenges
      • Presence of counterfeit drugs, along with the availability of alternate therapeutic technologies and medicines
  • Market Segmentation Analysis
    • Product Type: Increasing preference for the fenoverine capsule owing to their minimal taste and odor
    • End-Use: Evolving usage of fenoverine in home healthcare settings
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fenoverine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fenoverine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Burkina Faso Opens New Pharmaceutical Plant to Boost Health Independence and Economic Growth

Burkina Faso inaugurated its pharmaceutical manufacturing plant to produce low-cost generic drugs, primarily targeting the local supply of essential medications. Under the entity Propharm, Burkinabe pharmacists reported that the new facility initially focused on medications such as paracetamol, the antispasmodic agent phloroglucinol, and treatments for diarrhea, including oral rehydration salts and zinc. Situated on a 1.5-hectare site near Ouagadougou in Komsilga, this plant represents a critical step toward self-reliance, addressing the frequent shortages and high costs of drugs exacerbated by the heavy reliance on imports [Published On: 2023-05-29]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fenoverine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Fenoverine Market, highlighting leading vendors and their innovative profiles. These include American Custom Chemicals Corporation, Dayang Chem (Hangzhou) Co.,Ltd., Enomark, JoinHub Pharma, LGC Limited, Mars Therapeutics Private Limited, Medical Isotopes, Inc., Micro Labs Limited, Sri Krishna Pharmaceuticals Ltd., Synmosa Biopharma Corporation, and Taj Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Fenoverine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Capsules
    • Tablets
  • Application
    • Abdominal Spasms
    • Stomach Spasms
  • End-Use
    • Home Healthcare Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and the need for effective gastrointestinal treatments
      • 5.1.1.2. Expanding healthcare infrastructure and governmental initiatives
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations and side effects associated with fenoverine
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in drug delivery systems for fenoverine
      • 5.1.3.2. Collaborative research and development initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of counterfeit drugs, along with the availability of alternate therapeutic technologies and medicines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing preference for the fenoverine capsule owing to their minimal taste and odor
    • 5.2.2. End-Use: Evolving usage of fenoverine in home healthcare settings
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Fenoverine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Tablets

7. Fenoverine Market, by Application

  • 7.1. Introduction
  • 7.2. Abdominal Spasms
  • 7.3. Stomach Spasms

8. Fenoverine Market, by End-Use

  • 8.1. Introduction
  • 8.2. Home Healthcare Settings
  • 8.3. Hospitals & Clinics

9. Americas Fenoverine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fenoverine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fenoverine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Burkina Faso Opens New Pharmaceutical Plant to Boost Health Independence and Economic Growth
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FENOVERINE MARKET RESEARCH PROCESS
  • FIGURE 2. FENOVERINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FENOVERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FENOVERINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. FENOVERINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. FENOVERINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FENOVERINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FENOVERINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FENOVERINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FENOVERINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FENOVERINE MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FENOVERINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FENOVERINE MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FENOVERINE MARKET SIZE, BY ABDOMINAL SPASMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FENOVERINE MARKET SIZE, BY ABDOMINAL SPASMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FENOVERINE MARKET SIZE, BY STOMACH SPASMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FENOVERINE MARKET SIZE, BY STOMACH SPASMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FENOVERINE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FENOVERINE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FENOVERINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FENOVERINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 39. BRAZIL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. BRAZIL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 45. CANADA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. CANADA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. AUSTRALIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. CHINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. CHINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. INDIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. INDIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. INDONESIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDONESIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. JAPAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. JAPAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. MALAYSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. MALAYSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. PHILIPPINES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. SINGAPORE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. SINGAPORE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SOUTH KOREA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. TAIWAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. TAIWAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. THAILAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. THAILAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. VIETNAM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. VIETNAM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. DENMARK FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. DENMARK FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 159. EGYPT FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. EGYPT FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 165. FINLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. FINLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. FRANCE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FRANCE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. GERMANY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. GERMANY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. ISRAEL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. ISRAEL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 189. ITALY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ITALY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. NETHERLANDS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. NIGERIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NIGERIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. NORWAY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NORWAY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. POLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. POLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. QATAR FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. QATAR FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. RUSSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. RUSSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. SAUDI ARABIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. SPAIN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SPAIN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. SWEDEN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SWEDEN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWITZERLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. TURKEY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TURKEY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED KINGDOM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 279. FENOVERINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. FENOVERINE MARKET, FPNV POSITIONING MATRIX, 2023